Biotech Values

[DewDiligence]

>As recent cancer immunotherapy studies have shown , autoimmune side effects may correlate with anticancer effects , as they signal a reversal of immune tolerance. Chronic viral infections are also characterized by immune tolerance, and the most efficacious HCV drug on the market today, interferon, is also known for autoimmune side effects and exacerbation of existing autoimmune disease. This might a treatment area where it's necessary to tolerate quite a bit of bad in order to get the good.<

The language in the PR—terse as it is—does not sound encouraging at all. My guess: a 65% chance that ANA975 is history.